Precigen PGEN
NASDAQ PGEN
$7.11 -0.03 (-0.49%)
As of: Sep 4, 2026 · 3:59 PM EDT

Precigen (PGEN) Treasury Shares (2012 - 2025)

Precigen (PGEN) posted quarterly Treasury Shares of $2.9 million for Q1 2026, up 3592.26% year-over-year from $79000.0 in Q1 2025, and down 13.37% quarter-over-quarter from $3.4 million in Q4 2025.

Analysis

Precigen (PGEN) Treasury Shares (2012 - 2025) Analysis & Trends

Precigen (PGEN) has reported Treasury Shares for 11 consecutive years, with $2.9 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Treasury Shares rose 3592.26% year-over-year to $2.9 million; the TTM figure through Mar 2026 stood at $2.9 million (up 3592.26% YoY), while the FY2025 annual figure was $3.4 million, down 15.91% from the prior year.
  • Treasury Shares slipped to $2.9 million in Q1 2026 per PGEN's latest filing, from $3.4 million in the prior quarter.
  • Across five years, Treasury Shares topped out at $6.1 million in Q1 2024 and bottomed at $79000.0 in Q1 2025.
  • Historically, Treasury Shares has averaged $1.9 million across 5 years, with a median of $961534.0 in 2023.
  • Annual changes were most pronounced in 2025 — Treasury Shares sank 98.72% — and 2026, when it surged 3592.26%.
  • Precigen's Treasury Shares stood at $697815.0 in 2022, then jumped by 37.79% to $961534.0 in 2023, then jumped by 316.42% to $4.0 million in 2024, then retreated by 15.91% to $3.4 million in 2025, then fell by 13.37% to $2.9 million in 2026.
  • Business Quant data shows PGEN's Treasury Shares at $2.9 million in Q1 2026, $3.4 million in Q4 2025, and $1.7 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 36.40 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - 2.72 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Precigen 2.53 Bn 2.53 Bn 52.17 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 79,000.00
Jun 30, 2025 79,000.00
Mar 31, 2025 79,000.00
Mar 31, 2025 79,000.00
Dec 31, 2024 79,000.00
Dec 31, 2024 79,000.00
Jun 30, 2024 3.74 Mn
Jun 30, 2024 3.74 Mn
Mar 31, 2024 6.15 Mn
Mar 31, 2024 6.15 Mn
Jun 30, 2013 38.10 Mn
Jun 30, 2013 38.10 Mn
Dec 31, 2012 38.10 Mn
Dec 31, 2012 38.10 Mn